Neuromodulation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuromodulation stocks.

Neuromodulation Stocks Recent News

Date Stock Title
Nov 20 BSX Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio
Nov 20 BWAY BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
Nov 19 BSX Reasons to Retain BSX Stock in Your Portfolio for Now
Nov 19 BSX BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
Nov 19 BSX Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Nov 18 BSX Boston Sci stock climbs 5% on positive Watchman FLX data
Nov 18 NPCE What Makes NeuroPace (NPCE) a New Buy Stock
Nov 18 BSX Inside a $400 billion bet on the brain-computer interface revolution
Nov 18 NPCE Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade
Nov 18 BSX Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today
Nov 18 BSX Boston Scientific’s Watchman could be new option for patients post ablation: study
Nov 18 BSX The PFA race is heating up. Here’s where the market stands after J&J’s approval.
Nov 18 BSX Boston Scientific reports outcomes from trial of LAAC device
Nov 17 ZYXI A Note On Zynex, Inc.'s (NASDAQ:ZYXI) ROE and Debt To Equity
Nov 16 BSX Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
Nov 15 BSX Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)
Nov 15 NRXS NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript
Nov 15 NRXS NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage
Nov 15 BSX Boston Scientific closes acquisition of Axonics
Nov 15 BSX Boston Scientific Closes Acquisition of Axonics, Inc.
Neuromodulation

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to synaptic transmission in which an axonal terminal secretes neurotransmitters to target fast-acting receptors of only one particular partner neuron. Neuromodulators are neurotransmitters that diffuse through neural tissue to affect slow-acting receptors of many neurons. Major neuromodulators in the central nervous system include dopamine, serotonin, acetylcholine, histamine, and norepinephrine. Neuromodulators are known to have modulatory effects on target areas such as decorrelation of spiking, increase of firing rate, sharpening of spatial tuning curves, maintenance of increased spiking during working memory.A neuromodulator can be conceptualized as a neurotransmitter that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. Such neuromodulators end up spending a significant amount of time in the cerebrospinal fluid (CSF), influencing (or "modulating") the activity of several other neurons in the brain. For this reason, some neurotransmitters are also considered to be neuromodulators, such as serotonin and acetylcholine.Neuromodulation is often contrasted with classical fast synaptic transmission. In both cases the transmitter acts on local postsynaptic receptors, but in neuromodulation, the receptors are typically G-protein coupled receptors while in classical chemical neurotransmission, they are ligand-gated ion channels. Neurotransmission that involves metabotropic receptors (like G-protein linked receptors) often also involves voltage-gated ion channels, and is relatively slow. Conversely, neurotransmission that involves exclusively ligand-gated ion channels is much faster.
A related distinction is also sometimes drawn between modulator and driver synaptic inputs to a neuron, but here the emphasis is on modulating ongoing neuronal spiking versus causing that spiking.

Browse All Tags